Sign in
Author
|
Conference
|
Journal
|
Organization
|
Year
|
DOI
Look for results that meet for the following criteria:
since
equal to
before
between
and
Search in all fields of study
Limit my searches in the following fields of study
Agriculture Science
Arts & Humanities
Biology
Chemistry
Computer Science
Economics & Business
Engineering
Environmental Sciences
Geosciences
Material Science
Mathematics
Medicine
Physics
Social Science
Multidisciplinary
Co-authors
(82)
Antonio Brugarolas
7
Javier Maria Rodriguez (Javier María Rodríguez)
6
Javier Cortes (Javier Cortés)
6
Jesus Garcia-Foncillas (Jesús García-Foncillas)
5
Salvador Martin-Algarra (Salvador Martín-Algarra)
5
Journals
(15)
AMER J CLIN ONCOL-CANC CLIN T
2
Cancer
2
CANCER CHEMOTHER PHARMACOL
2
CANCER METAST REV
2
ONCOLOGY-BASEL
2
Keywords
(58)
Embed
Subscribe
Academic
Authors
Emiliano Calvo
Emiliano Calvo,University of Texas Health Science Center at San Antonio,Oncology,Pharmacology,Anatomy
Edit
Emiliano Calvo
University of Texas Health Science Center at San Antonio
Publications:
22
|
Citations:
118
Fields:
Oncology
,
Pharmacology
,
Anatomy
View FAQ about top research areas and Fields of study
Collaborated with
82 co-authors
from 2000 to 2010
|
Cited by
559 authors
Cumulative
Annual
Sort by:
Publications
(22)
BibTeX
|
RIS
|
RefWorks
Download
Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: a phase 2 study (SOGUG-02-06)
(
Citations: 5
)
Joaquim Bellmunt
,
José Manuel Trigo
,
Emiliano Calvo
,
Joan Carles
,
José L Pérez-Gracia
,
Jordi Rubió
,
Juan Antonio Virizuela
,
Rafael López
,
Martín Lázaro
,
Joan Albanell
Journal:
Lancet Oncology - LANCET ONCOL
, vol. 11, no. 4, pp. 350-357, 2010
Updated recommendations from the Spanish Oncology Genitourinary Group on the treatment of advanced renal cell carcinoma
(
Citations: 1
)
Emiliano Calvo
,
Pablo Maroto
,
Xavier García del Muro
,
Miguel Ángel Climent
,
José Luis González-Larriba
,
Emilio Esteban
,
Rafael López
,
Luis Paz-Ares
,
Joaquim Bellmunt
,
Daniel Castellano
Journal:
Cancer and Metastasis Reviews - CANCER METAST REV
, vol. 29, no. S1, pp. 1-10, 2010
Update from the Spanish Oncology Genitourinary Group on the treatment of advanced renal cell carcinoma: focus on special populations
Emiliano Calvo
,
Pablo Maroto
,
Xavier García del Muro
,
Miguel Ángel Climent
,
José Luis González-Larriba
,
Emilio Esteban
,
Rafael López
,
Luis Paz-Ares
,
Joaquim Bellmunt
,
Daniel Castellano
Journal:
Cancer and Metastasis Reviews - CANCER METAST REV
, vol. 29, no. S1, pp. 11-20, 2010
Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors
(
Citations: 6
)
Chia-Chi Lin
,
Emiliano Calvo
,
Kyriakos P. Papadopoulos
,
Amita Patnaik
,
John Sarantopoulos
,
Alain C. Mita
,
Glenn G. Preston
,
Monica M. Mita
,
Jordi Rodon
,
Theresa Mays
,
I-Tien Yeh
,
Pat O’Rourke
http://academic.research.microsoft.com/io.ashx?type=5&id=32507149&selfId1=21152956&selfId2=0&maxNumber=12&query=
Journal:
Cancer Chemotherapy and Pharmacology - CANCER CHEMOTHER PHARMACOL
, vol. 63, no. 6, pp. 1065-1071, 2009
Recommendations from the Spanish Oncology Genitourinary Group for the treatment of metastatic renal cancer
(
Citations: 3
)
Joaquim Bellmunt
,
Emiliano Calvo
,
Daniel Castellano
,
Miguel Ángel Climent
,
Emilio Esteban
,
Xavier García del Muro
,
José Luis González-Larriba
,
Pablo Maroto
,
José Manuel Trigo
Journal:
Cancer Chemotherapy and Pharmacology - CANCER CHEMOTHER PHARMACOL
, vol. 63, no. S1, pp. 1-13, 2009
Sort by:
Citations
(118 times by 114 publications)
Anti-EGFR Monoclonal Antibodies for Treatment of Colorectal Cancers: Development of Cetuximab and Panitumumab
(
Citations: 1
)
Benoit You
,
Eric X. Chen
Journal:
Journal of Clinical Pharmacology - J CLIN PHARMACOL
, vol. 52, no. 2, pp. 128-155, 2012
Substrate-dependent modulation of the catalytic activity of CYP3A by erlotinib
Pei-pei Dong
,
Zhong-ze Fang
,
Yan-yan Zhang
,
Guang-bo Ge
,
Yu-xi Mao
,
Liang-liang Zhu
,
Yan-qing Qu
,
Wei Li
,
Li-ming Wang
,
Chang-xiao Liu
,
Ling Yang
Journal:
Acta Pharmacologica Sinica - ACTA PHARMACOL SIN
, vol. 32, no. 3, pp. 399-407, 2011
Combination therapy with sorafenib and S-1 for renal cell carcinoma producing granulocyte colony-stimulating factor
Tatsuya Takayama
,
Mana Kinoshita
,
Yutaka Kurita
,
Soichi Mugiya
,
Satoshi Baba
,
Seiichiro Ozono
Journal:
International Journal of Clinical Oncology - INT J CLIN ONCOL
, vol. 16, no. 3, pp. 275-278, 2011
Metronomic chemotherapy: new rationale for new directions
(
Citations: 12
)
Maria Kavallaris
,
Nicolas André
,
Eddy Pasquier
Journal:
Nature Reviews Clinical Oncology - NAT REV CLIN ONCOL
, vol. 7, no. 8, pp. 455-465, 2010
RECIST revised: implications for the radiologist. A review article on the modified RECIST guideline
(
Citations: 5
)
Els L. van Persijn van Meerten
,
Hans Gelderblom
,
Johan L. Bloem
Journal:
European Radiology - EUROPEAN RADIOL
, vol. 20, no. 6, pp. 1456-1467, 2010
Comments